RedHill Biopharma (NASDAQ:RDHL) Share Price Passes Below 200-Day Moving Average – Time to Sell?
RedHill Biopharma Ltd. (NASDAQ:RDHL – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $76.46 and traded as low as $6.51. RedHill Biopharma shares last traded at $6.58, with a volume of 4,230 shares trading hands. Analyst Ratings Changes Separately, StockNews.com assumed […]
More Stories
Traders Purchase Large Volume of Call Options on Kirkland’s (NASDAQ:KIRK)
Kirkland’s, Inc. (NASDAQ:KIRK – Get Free Report) was the target of some unusual options trading activity on Wednesday. Traders purchased...
Chicago Rivet & Machine (NYSEAMERICAN:CVR) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a research report sent to...
Melrose Industries’ (MRO) Overweight Rating Reiterated at JPMorgan Chase & Co.
JPMorgan Chase & Co. restated their overweight rating on shares of Melrose Industries (LON:MRO – Free Report) in a research...
Canaccord Genuity Group Has Lowered Expectations for Aurrigo International (LON:AURR) Stock Price
Aurrigo International (LON:AURR – Free Report) had its price objective decreased by Canaccord Genuity Group from GBX 165 ($2.03) to...
BJ’s Restaurants (NASDAQ:BJRI) Cut to Market Perform at Oppenheimer
Oppenheimer downgraded shares of BJ’s Restaurants (NASDAQ:BJRI – Free Report) from an outperform rating to a market perform rating in...
HC Wainwright Reiterates “Buy” Rating for Arcturus Therapeutics (NASDAQ:ARCT)
HC Wainwright reissued their buy rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research note published...